Delivery Order SPE2DB20D2014-SPE2DB25FC07K
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $2,189.41 and a period of performance ending on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $1,499.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial 10mL. The contract has an ultimate completion date of April 2, 2025 and is not associated with a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL Vial 10mL, a critical diabetes medication. The total ceiling value of the contract is $1,809.60, with a period of performance through January 30, 2025. The contract was awarded on a firm-fixed price basis without any set-aside designation, indicating open...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4564617692 units of Insulin Aspart 100 Unit/mL Vial 10mL. The award is a Firm Fixed Price contract with a ceiling value of $11,209.30 and a performance period ending on May 16, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial, 10 mL. The contract has a ceiling value of $1,175.27 and a period of performance through November 13, 2023. The contract is a firm fixed-price delivery order type, with no set-aside requirements indicated. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,743,151 units of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $4,266.02. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract has a ceiling value of $2,155.06 and a period of performance through May 23, 2025. This award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 10 milliliter vials of insulin aspart 100 unit/milliliter. The contract has a firm fixed price of $2,276.20 and an ultimate completion date of May 23, 2025. The award is not set-aside and was issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.20 fixed-price delivery order is for the supply of 4568200468 Insulin Aspart 100 Unit/mL Vials (10mL), with a performance period ending on May 12, 2025. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract is a firm fixed price delivery order with a ceiling value of $6,144.50 and a period of performance through August 20, 2024. The award is not associated with a set-aside designation, indicating open competition. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...